Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pulmonary Surfactants | 1 | 2020 | 128 | 0.75 | Why? |
| Denture, Overlay | 1 | 2017 | 2 | 0.72 | Why? |
| Denture Design | 1 | 2017 | 4 | 0.72 | Why? |
| Dental Prosthesis, Implant-Supported | 1 | 2017 | 14 | 0.71 | Why? |
| Drug Delivery Systems | 2 | 2017 | 1365 | 0.63 | Why? |
| Blood Coagulation Disorders, Inherited | 3 | 2021 | 82 | 0.60 | Why? |
| High-Intensity Focused Ultrasound Ablation | 1 | 2015 | 19 | 0.60 | Why? |
| Drug Liberation | 1 | 2015 | 141 | 0.56 | Why? |
| Hyperthermia, Induced | 1 | 2015 | 106 | 0.53 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.44 | Why? |
| Nanostructures | 1 | 2018 | 700 | 0.42 | Why? |
| Proteins | 1 | 2018 | 921 | 0.41 | Why? |
| Enoxaparin | 3 | 2021 | 1064 | 0.39 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.29 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.26 | Why? |
| Drug Carriers | 2 | 2020 | 590 | 0.25 | Why? |
| Nanoparticles | 1 | 2015 | 2040 | 0.24 | Why? |
| Metoclopramide | 1 | 2020 | 9 | 0.22 | Why? |
| Factor V Deficiency | 1 | 2020 | 30 | 0.22 | Why? |
| Factor X Deficiency | 1 | 2020 | 17 | 0.22 | Why? |
| Hiccup | 1 | 2020 | 41 | 0.21 | Why? |
| Chlorpromazine | 1 | 2020 | 130 | 0.20 | Why? |
| Iran | 6 | 2021 | 5467 | 0.20 | Why? |
| Drug Dosage Calculations | 1 | 2020 | 243 | 0.19 | Why? |
| Tissue Adhesions | 1 | 2018 | 33 | 0.19 | Why? |
| Thrombosis | 4 | 2021 | 7504 | 0.18 | Why? |
| Denture Retention | 1 | 2017 | 1 | 0.18 | Why? |
| Surface-Active Agents | 1 | 2020 | 267 | 0.18 | Why? |
| Stress, Mechanical | 1 | 2018 | 143 | 0.18 | Why? |
| Finite Element Analysis | 1 | 2017 | 27 | 0.18 | Why? |
| Dry Powder Inhalers | 1 | 2017 | 36 | 0.18 | Why? |
| Chitosan | 1 | 2020 | 196 | 0.17 | Why? |
| Dental Pulp | 1 | 2017 | 48 | 0.17 | Why? |
| Bevacizumab | 1 | 2018 | 149 | 0.17 | Why? |
| Mandible | 1 | 2017 | 72 | 0.17 | Why? |
| Dose-Response Relationship, Drug | 3 | 2021 | 3776 | 0.16 | Why? |
| Hemorrhage | 4 | 2021 | 3013 | 0.16 | Why? |
| Pericardium | 1 | 2018 | 228 | 0.16 | Why? |
| Acrylic Resins | 1 | 2015 | 48 | 0.15 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.15 | Why? |
| Anticoagulants | 3 | 2021 | 9563 | 0.14 | Why? |
| Gels | 1 | 2015 | 111 | 0.14 | Why? |
| Angiogenesis Inhibitors | 1 | 2018 | 395 | 0.14 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.14 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2020 | 669 | 0.13 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.12 | Why? |
| Doxorubicin | 1 | 2015 | 313 | 0.12 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.12 | Why? |
| Double-Blind Method | 2 | 2020 | 5988 | 0.12 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.12 | Why? |
| Stem Cells | 1 | 2017 | 595 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2015 | 881 | 0.10 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.09 | Why? |
| Health Education | 1 | 2020 | 1539 | 0.09 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.09 | Why? |
| Lung | 1 | 2017 | 31049 | 0.09 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 5002 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.07 | Why? |
| Lung Neoplasms | 2 | 2020 | 3228 | 0.07 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Consanguinity | 1 | 2020 | 50 | 0.05 | Why? |
| Aerosols | 1 | 2017 | 5393 | 0.05 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.05 | Why? |
| Tranexamic Acid | 1 | 2020 | 121 | 0.05 | Why? |
| Hemostatics | 1 | 2020 | 142 | 0.05 | Why? |
| Blood Coagulation Factors | 1 | 2020 | 223 | 0.05 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.05 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.05 | Why? |
| Humans | 15 | 2021 | 930598 | 0.05 | Why? |
| Biocompatible Materials | 1 | 2020 | 214 | 0.04 | Why? |
| Disease Resistance | 1 | 2020 | 236 | 0.04 | Why? |
| Thrombocytopenia | 2 | 2021 | 2093 | 0.04 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.04 | Why? |
| Hematologic Tests | 1 | 2020 | 521 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Venous Thrombosis | 2 | 2021 | 2739 | 0.04 | Why? |
| Cell Survival | 1 | 2020 | 1581 | 0.03 | Why? |
| Overweight | 1 | 2020 | 916 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2021 | 2324 | 0.03 | Why? |
| Animals | 2 | 2020 | 78931 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.03 | Why? |
| Cesarean Section | 1 | 2020 | 2089 | 0.03 | Why? |
| Kidney Diseases | 1 | 2020 | 1434 | 0.02 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Dabbagh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(149)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(131)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_